Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF EQUITY

v3.8.0.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Total
Beginning balance, shares at Mar. 31, 2016 7,622,393        
Beginning balance, value at Mar. 31, 2016 $ 7,621 $ 88,047,142 $ (86,502,043) $ (50,354) $ 1,502,366
Issuances of common stock for cash under at the market program, shares 216,078        
Issuances of common stock for cash under at the market program, value $ 216 954,889 955,105
Issuances of common stock and warrants under registered direct financing, shares 773,000        
Issuances of common stock and warrants under registered direct financing, value $ 773 1,803,477 1,804,250
Issuances of common stock under conversions of convertible notes and related accrued interest, shares 33,091        
Issuances of common stock under conversions of convertible notes and related accrued interest, value $ 33 144,686 144,719
Warrant repricing expense 345,841 345,841
Loss on debt extinguishment 558,198 558,198
Debt discount on convertible notes payable 783,868 783,868
Issuance of common shares for repurchase of restricted stock units, shares 149,864        
Issuance of common shares for repurchase of restricted stock units, value $ 150 (378,668) (378,518)
Exercise of cashless warrants, shares 2,660        
Exercise of cashless warrants, value $ 3 (3)
Stock-based compensation expense 2,186,309 2,186,309
Net loss (7,276,113) (30,613) (7,306,726)
Ending balance, shares at Mar. 31, 2017 8,797,086        
Ending balance, value at Mar. 31, 2017 $ 8,796 94,445,739 (93,778,156) (80,967) 595,412
Issuances of common stock for cash under at the market program, shares 941,504        
Issuances of common stock for cash under at the market program, value $ 941 2,104,027 2,104,968
Issuances of common stock for cash under warrant exercises, shares 2,160,350        
Issuances of common stock for cash under warrant exercises, value $ 2,160 2,231,642 2,233,802
Issuances of common stock under conversions of convertible notes and related accrued interest, shares 120,922        
Issuances of common stock under conversions of convertible notes and related accrued interest, value $ 121 362,642 362,763
Issuance of common stock in public offering, shares 5,454,546        
Issuance of common stock in public offering, value $ 5,455 5,284,280 5,289,735
Loss on debt extinguishment         376,909
Issuance of common shares for repurchase of restricted stock units, shares 175,262        
Issuance of common shares for repurchase of restricted stock units, value $ 175 (278,808) (278,633)
Common stock issued for services, shares 15,000        
Common stock issued for services, value $ 15 33,585 33,600
Issuance of common shares pursuant to warrant exchanges, shares 74,841        
Issuance of common shares pursuant to warrant exchanges, value $ 77 130,138 130,215
Stock-based compensation expense 1,260,769   1,260,769
Net loss (5,679,558) (20,279) (5,699,837)
Ending balance, shares at Mar. 31, 2018 17,739,511        
Ending balance, value at Mar. 31, 2018 $ 17,740 $ 105,574,014 $ (99,457,714) $ (101,246) $ 6,032,794